カテゴリ： 世界, 医療/バイオ, Market Monitor Global

無細胞ジフテリア百日咳菌インフルエンザ菌B型混合ワクチンのグローバル市場展望 2023年-2029年：0.5mL用量、1.5mL用量

■ 英語タイトル：Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Market, Global Outlook and Forecast 2023-2029

調査会社Market Monitor Global社が発行したリサーチレポート（データ管理コード：MMG23DC14208）■ 発行会社/調査会社：Market Monitor Global
■ 商品コード：MMG23DC14208
■ 発行日：2023年12月
■ 調査対象地域：グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど
■ 産業分野：医薬品
■ ページ数：70
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（受注後2-3営業日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,250 ⇒換算￥494,000見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD4,225 ⇒換算￥642,200見積依頼/購入/質問フォーム
Enterprise User（閲覧人数制限なし）USD4,875 ⇒換算￥741,000見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※Market Monitor Global社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[無細胞ジフテリア百日咳菌インフルエンザ菌B型混合ワクチンのグローバル市場展望 2023年-2029年：0.5mL用量、1.5mL用量]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

当調査レポートは次の情報を含め、世界の無細胞ジフテリア百日咳菌インフルエンザ菌B型混合ワクチン市場規模と予測を収録しています。・世界の無細胞ジフテリア百日咳菌インフルエンザ菌B型混合ワクチン市場：売上、2018年-2023年、2024年-2029年
・世界の無細胞ジフテリア百日咳菌インフルエンザ菌B型混合ワクチン市場：販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界の無細胞ジフテリア百日咳菌インフルエンザ菌B型混合ワクチン市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「0.5mL用量」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。

無細胞ジフテリア百日咳菌インフルエンザ菌B型混合ワクチンのグローバル主要企業は、Sanofi、 Beijing Minhai Biotechnology、 Kangtai、 Walvax Biotechnology、 HualanBioなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

MARKET MONITOR GLOBAL（MMG）は、無細胞ジフテリア百日咳菌インフルエンザ菌B型混合ワクチンのメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別市場分析】

世界の無細胞ジフテリア百日咳菌インフルエンザ菌B型混合ワクチン市場：タイプ別、2018年-2023年、2024年-2029年
世界の無細胞ジフテリア百日咳菌インフルエンザ菌B型混合ワクチン市場：タイプ別市場シェア、2022年
・0.5mL用量、1.5mL用量

世界の無細胞ジフテリア百日咳菌インフルエンザ菌B型混合ワクチン市場：用途別、2018年-2023年、2024年-2029年
世界の無細胞ジフテリア百日咳菌インフルエンザ菌B型混合ワクチン市場：用途別市場シェア、2022年
・病院、診療所、CDC

世界の無細胞ジフテリア百日咳菌インフルエンザ菌B型混合ワクチン市場：地域・国別、2018年-2023年、2024年-2029年
世界の無細胞ジフテリア百日咳菌インフルエンザ菌B型混合ワクチン市場：地域別市場シェア、2022年
・北米：アメリカ、カナダ、メキシコ
・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
・アジア：中国、日本、韓国、東南アジア、インド
・南米：ブラジル、アルゼンチン
・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE

【競合分析】

また、当レポートは主要な市場参加者の分析を提供します。
・主要企業における無細胞ジフテリア百日咳菌インフルエンザ菌B型混合ワクチンのグローバル売上、2018年-2023年
・主要企業における無細胞ジフテリア百日咳菌インフルエンザ菌B型混合ワクチンのグローバル売上シェア、2022年
・主要企業における無細胞ジフテリア百日咳菌インフルエンザ菌B型混合ワクチンのグローバル販売量、2018年-2023年
・主要企業における無細胞ジフテリア百日咳菌インフルエンザ菌B型混合ワクチンのグローバル販売量シェア、2022年

さらに、当レポートは主要企業のプロファイルを提示します。
Sanofi、 Beijing Minhai Biotechnology、 Kangtai、 Walvax Biotechnology、 HualanBio

*************************************************************

・調査・分析レポートの概要
無細胞ジフテリア百日咳菌インフルエンザ菌B型混合ワクチン市場の定義
市場セグメント
世界の無細胞ジフテリア百日咳菌インフルエンザ菌B型混合ワクチン市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界の無細胞ジフテリア百日咳菌インフルエンザ菌B型混合ワクチン市場規模
世界の無細胞ジフテリア百日咳菌インフルエンザ菌B型混合ワクチン市場規模：2022年 VS 2029年
世界の無細胞ジフテリア百日咳菌インフルエンザ菌B型混合ワクチン市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでの無細胞ジフテリア百日咳菌インフルエンザ菌B型混合ワクチンの売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業の無細胞ジフテリア百日咳菌インフルエンザ菌B型混合ワクチン製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分：0.5mL用量、1.5mL用量
無細胞ジフテリア百日咳菌インフルエンザ菌B型混合ワクチンのタイプ別グローバル売上・予測

・用途別市場分析
用途区分：病院、診療所、CDC
無細胞ジフテリア百日咳菌インフルエンザ菌B型混合ワクチンの用途別グローバル売上・予測

・地域別市場分析
地域別無細胞ジフテリア百日咳菌インフルエンザ菌B型混合ワクチン市場規模 2022年と2029年
地域別無細胞ジフテリア百日咳菌インフルエンザ菌B型混合ワクチン売上・予測
北米市場：アメリカ、カナダ、メキシコ
ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場：中国、日本、韓国、東南アジア、インド
南米市場：ブラジル、アルゼンチン
中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE

・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど）
Sanofi、 Beijing Minhai Biotechnology、 Kangtai、 Walvax Biotechnology、 HualanBio
...

This research report provides a comprehensive analysis of the Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine market, focusing on the current trends, market dynamics, and future prospects. The report explores the global Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine market, including major regions such as North America, Europe, Asia-Pacific, and emerging markets. It also examines key factors driving the growth of Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine, challenges faced by the industry, and potential opportunities for market players.
The global Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine market has witnessed rapid growth in recent years, driven by increasing environmental concerns, government incentives, and advancements in technology. The Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine market presents opportunities for various stakeholders, including Hospital, Clinic. Collaboration between the private sector and governments can accelerate the development of supportive policies, research and development efforts, and investment in Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine market. Additionally, the growing consumer demand present avenues for market expansion.
The global Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Key Features:
The research report on the Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine market includes several key features to provide comprehensive insights and facilitate decision-making for stakeholders.
Executive Summary: The report provides overview of the key findings, market trends, and major insights of the Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine market.
Market Overview: The report provides a comprehensive overview of the Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine market, including its definition, historical development, and current market size. It covers market segmentation by Type (e.g., 0.5mL Dose, 1.5mL Dose), region, and application, highlighting the key drivers, challenges, and opportunities within each segment.
Market Dynamics: The report analyses the market dynamics driving the growth and development of the Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine market. The report includes an assessment of government policies and regulations, technological advancements, consumer trends and preferences, infrastructure development, and industry collaborations. This analysis helps stakeholders understand the factors influencing the Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine market’s trajectory.
Competitive Landscape: The report provides an in-depth analysis of the competitive landscape within the Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine market. It includes profiles of major market players, their market share, strategies, product portfolios, and recent developments.
Market Segmentation and Forecast: The report segment the Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine market based on various parameters, such as by Type, region, and by Application. It provides market size and growth forecasts for each segment, supported by quantitative data and analysis. This helps stakeholders identify growth opportunities and make informed investment decisions.
Technological Trends: The report should highlight the key technological trends shaping the Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine market, such as advancements in Type One technology and emerging substitutes. It analyses the impact of these trends on market growth, adoption rates, and consumer preferences.
Market Challenges and Opportunities: The report identify and analyses the major challenges faced by the Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine market, such as technical bottleneck, cost limitations, and high entry barrier. It also highlights the opportunities for market growth, such as government incentives, emerging markets, and collaborations between stakeholders.
Regulatory and Policy Analysis: The report should assess the regulatory and policy landscape for Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine, including government incentives, emission standards, and infrastructure development plans. It should analyse the impact of these policies on market growth and provide insights into future regulatory developments.
Recommendations and Conclusion: The report conclude with actionable recommendations for stakeholders, such as Application One Consumer, policymakers, investors, and infrastructure providers. These recommendations should be based on the research findings and address key challenges and opportunities within the Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine market.
Supporting Data and Appendices: The report include supporting data, charts, and graphs to substantiate the analysis and findings. It also includes appendices with additional detailed information, such as data sources, survey questionnaires, and detailed market forecasts.
Market Segmentation
Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
0.5mL Dose
1.5mL Dose
Market segment by Application
Hospital
Clinic
CDC
Global Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Major players covered
Sanofi
Beijing Minhai Biotechnology
Kangtai
Walvax Biotechnology
HualanBio
Outline of Major Chapters:
Chapter 1: Introduces the definition of Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine, market overview.
Chapter 2: Global Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine market size in revenue and volume.
Chapter 3: Detailed analysis of Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.

*** レポート目次（コンテンツ）***

1 Introduction to Research & Analysis Reports
1.1 Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Overall Market Size
2.1 Global Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Market Size: 2022 VS 2029
2.2 Global Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Sales: 2018-2029
3 Company Landscape
3.1 Top Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Players in Global Market
3.2 Top Global Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Companies Ranked by Revenue
3.3 Global Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Revenue by Companies
3.4 Global Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Sales by Companies
3.5 Global Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Product Type
3.8 Tier 1, Tier 2 and Tier 3 Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Players in Global Market
3.8.1 List of Global Tier 1 Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Companies
3.8.2 List of Global Tier 2 and Tier 3 Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Market Size Markets, 2022 & 2029
4.1.2 0.5mL Dose
4.1.3 1.5mL Dose
4.2 By Type – Global Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Revenue & Forecasts
4.2.1 By Type – Global Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Revenue, 2018-2023
4.2.2 By Type – Global Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Revenue, 2024-2029
4.2.3 By Type – Global Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Revenue Market Share, 2018-2029
4.3 By Type – Global Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Sales & Forecasts
4.3.1 By Type – Global Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Sales, 2018-2023
4.3.2 By Type – Global Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Sales, 2024-2029
4.3.3 By Type – Global Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Sales Market Share, 2018-2029
4.4 By Type – Global Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Market Size, 2022 & 2029
5.1.2 Hospital
5.1.3 Clinic
5.1.4 CDC
5.2 By Application – Global Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Revenue & Forecasts
5.2.1 By Application – Global Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Revenue, 2018-2023
5.2.2 By Application – Global Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Revenue, 2024-2029
5.2.3 By Application – Global Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Revenue Market Share, 2018-2029
5.3 By Application – Global Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Sales & Forecasts
5.3.1 By Application – Global Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Sales, 2018-2023
5.3.2 By Application – Global Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Sales, 2024-2029
5.3.3 By Application – Global Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Sales Market Share, 2018-2029
5.4 By Application – Global Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Market Size, 2022 & 2029
6.2 By Region – Global Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Revenue & Forecasts
6.2.1 By Region – Global Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Revenue, 2018-2023
6.2.2 By Region – Global Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Revenue, 2024-2029
6.2.3 By Region – Global Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Revenue Market Share, 2018-2029
6.3 By Region – Global Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Sales & Forecasts
6.3.1 By Region – Global Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Sales, 2018-2023
6.3.2 By Region – Global Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Sales, 2024-2029
6.3.3 By Region – Global Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Revenue, 2018-2029
6.4.2 By Country – North America Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Sales, 2018-2029
6.4.3 US Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Market Size, 2018-2029
6.4.4 Canada Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Market Size, 2018-2029
6.4.5 Mexico Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Revenue, 2018-2029
6.5.2 By Country – Europe Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Sales, 2018-2029
6.5.3 Germany Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Market Size, 2018-2029
6.5.4 France Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Market Size, 2018-2029
6.5.5 U.K. Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Market Size, 2018-2029
6.5.6 Italy Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Market Size, 2018-2029
6.5.7 Russia Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Market Size, 2018-2029
6.5.8 Nordic Countries Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Market Size, 2018-2029
6.5.9 Benelux Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Revenue, 2018-2029
6.6.2 By Region – Asia Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Sales, 2018-2029
6.6.3 China Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Market Size, 2018-2029
6.6.4 Japan Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Market Size, 2018-2029
6.6.5 South Korea Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Market Size, 2018-2029
6.6.6 Southeast Asia Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Market Size, 2018-2029
6.6.7 India Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Revenue, 2018-2029
6.7.2 By Country – South America Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Sales, 2018-2029
6.7.3 Brazil Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Market Size, 2018-2029
6.7.4 Argentina Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Sales, 2018-2029
6.8.3 Turkey Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Market Size, 2018-2029
6.8.4 Israel Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Market Size, 2018-2029
6.8.5 Saudi Arabia Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Market Size, 2018-2029
6.8.6 UAE Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Sanofi
7.1.1 Sanofi Company Summary
7.1.2 Sanofi Business Overview
7.1.3 Sanofi Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Major Product Offerings
7.1.4 Sanofi Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Sales and Revenue in Global (2018-2023)
7.1.5 Sanofi Key News & Latest Developments
7.2 Beijing Minhai Biotechnology
7.2.1 Beijing Minhai Biotechnology Company Summary
7.2.2 Beijing Minhai Biotechnology Business Overview
7.2.3 Beijing Minhai Biotechnology Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Major Product Offerings
7.2.4 Beijing Minhai Biotechnology Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Sales and Revenue in Global (2018-2023)
7.2.5 Beijing Minhai Biotechnology Key News & Latest Developments
7.3 Kangtai
7.3.1 Kangtai Company Summary
7.3.2 Kangtai Business Overview
7.3.3 Kangtai Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Major Product Offerings
7.3.4 Kangtai Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Sales and Revenue in Global (2018-2023)
7.3.5 Kangtai Key News & Latest Developments
7.4 Walvax Biotechnology
7.4.1 Walvax Biotechnology Company Summary
7.4.2 Walvax Biotechnology Business Overview
7.4.3 Walvax Biotechnology Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Major Product Offerings
7.4.4 Walvax Biotechnology Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Sales and Revenue in Global (2018-2023)
7.4.5 Walvax Biotechnology Key News & Latest Developments
7.5 HualanBio
7.5.1 HualanBio Company Summary
7.5.2 HualanBio Business Overview
7.5.3 HualanBio Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Major Product Offerings
7.5.4 HualanBio Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Sales and Revenue in Global (2018-2023)
7.5.5 HualanBio Key News & Latest Developments
8 Global Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Production Capacity, Analysis
8.1 Global Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Production Capacity, 2018-2029
8.2 Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Production Capacity of Key Manufacturers in Global Market
8.3 Global Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Supply Chain Analysis
10.1 Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Industry Value Chain
10.2 Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Upstream Market
10.3 Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List of Tables
Table 1. Key Players of Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine in Global Market
Table 2. Top Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Revenue Share by Companies, 2018-2023
Table 5. Global Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Sales by Companies, (K Units), 2018-2023
Table 6. Global Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Price (2018-2023) & (US$/Unit)
Table 8. Global Manufacturers Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Product Type
Table 9. List of Global Tier 1 Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type – Global Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Global Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Revenue (US$, Mn), 2024-2029
Table 14. By Type - Global Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Sales (K Units), 2018-2023
Table 15. By Type - Global Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Sales (K Units), 2024-2029
Table 16. By Application – Global Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Revenue, (US$, Mn), 2022 & 2029
Table 17. By Application - Global Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Revenue (US$, Mn), 2024-2029
Table 19. By Application - Global Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Sales (K Units), 2018-2023
Table 20. By Application - Global Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Sales (K Units), 2024-2029
Table 21. By Region – Global Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Revenue, (US$, Mn), 2022 VS 2029
Table 22. By Region - Global Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Revenue (US$, Mn), 2024-2029
Table 24. By Region - Global Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Sales (K Units), 2018-2023
Table 25. By Region - Global Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Sales (K Units), 2024-2029
Table 26. By Country - North America Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Revenue, (US$, Mn), 2024-2029
Table 28. By Country - North America Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Sales, (K Units), 2018-2023
Table 29. By Country - North America Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Sales, (K Units), 2024-2029
Table 30. By Country - Europe Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Revenue, (US$, Mn), 2024-2029
Table 32. By Country - Europe Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Sales, (K Units), 2018-2023
Table 33. By Country - Europe Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Sales, (K Units), 2024-2029
Table 34. By Region - Asia Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Revenue, (US$, Mn), 2024-2029
Table 36. By Region - Asia Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Sales, (K Units), 2018-2023
Table 37. By Region - Asia Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Sales, (K Units), 2024-2029
Table 38. By Country - South America Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Revenue, (US$, Mn), 2024-2029
Table 40. By Country - South America Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Sales, (K Units), 2018-2023
Table 41. By Country - South America Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Sales, (K Units), 2024-2029
Table 42. By Country - Middle East & Africa Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Revenue, (US$, Mn), 2024-2029
Table 44. By Country - Middle East & Africa Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Sales, (K Units), 2018-2023
Table 45. By Country - Middle East & Africa Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Sales, (K Units), 2024-2029
Table 46. Sanofi Company Summary
Table 47. Sanofi Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Product Offerings
Table 48. Sanofi Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 49. Sanofi Key News & Latest Developments
Table 50. Beijing Minhai Biotechnology Company Summary
Table 51. Beijing Minhai Biotechnology Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Product Offerings
Table 52. Beijing Minhai Biotechnology Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 53. Beijing Minhai Biotechnology Key News & Latest Developments
Table 54. Kangtai Company Summary
Table 55. Kangtai Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Product Offerings
Table 56. Kangtai Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 57. Kangtai Key News & Latest Developments
Table 58. Walvax Biotechnology Company Summary
Table 59. Walvax Biotechnology Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Product Offerings
Table 60. Walvax Biotechnology Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 61. Walvax Biotechnology Key News & Latest Developments
Table 62. HualanBio Company Summary
Table 63. HualanBio Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Product Offerings
Table 64. HualanBio Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 65. HualanBio Key News & Latest Developments
Table 66. Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Production Capacity (K Units) of Key Manufacturers in Global Market, 2021-2023 (K Units)
Table 67. Global Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Capacity Market Share of Key Manufacturers, 2021-2023
Table 68. Global Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Production by Region, 2018-2023 (K Units)
Table 69. Global Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Production by Region, 2024-2029 (K Units)
Table 70. Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Market Opportunities & Trends in Global Market
Table 71. Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Market Drivers in Global Market
Table 72. Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Market Restraints in Global Market
Table 73. Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Raw Materials
Table 74. Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Raw Materials Suppliers in Global Market
Table 75. Typical Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Downstream
Table 76. Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Downstream Clients in Global Market
Table 77. Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Segment by Type in 2022
Figure 2. Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Segment by Application in 2022
Figure 3. Global Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Revenue, 2018-2029 (US$, Mn)
Figure 7. Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Sales in Global Market: 2018-2029 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Revenue in 2022
Figure 9. By Type - Global Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Revenue, (US$, Mn), 2022 & 2029
Figure 10. By Type - Global Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Revenue Market Share, 2018-2029
Figure 11. By Type - Global Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Sales Market Share, 2018-2029
Figure 12. By Type - Global Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Price (US$/Unit), 2018-2029
Figure 13. By Application - Global Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Revenue, (US$, Mn), 2022 & 2029
Figure 14. By Application - Global Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Revenue Market Share, 2018-2029
Figure 15. By Application - Global Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Sales Market Share, 2018-2029
Figure 16. By Application - Global Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Price (US$/Unit), 2018-2029
Figure 17. By Region - Global Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Revenue, (US$, Mn), 2022 & 2029
Figure 18. By Region - Global Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Revenue Market Share, 2018-2029
Figure 20. By Region - Global Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Sales Market Share, 2018-2029
Figure 21. By Country - North America Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Revenue Market Share, 2018-2029
Figure 22. By Country - North America Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Sales Market Share, 2018-2029
Figure 23. US Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Revenue, (US$, Mn), 2018-2029
Figure 24. Canada Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Revenue, (US$, Mn), 2018-2029
Figure 25. Mexico Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Revenue, (US$, Mn), 2018-2029
Figure 26. By Country - Europe Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Revenue Market Share, 2018-2029
Figure 27. By Country - Europe Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Sales Market Share, 2018-2029
Figure 28. Germany Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Revenue, (US$, Mn), 2018-2029
Figure 29. France Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Revenue, (US$, Mn), 2018-2029
Figure 30. U.K. Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Revenue, (US$, Mn), 2018-2029
Figure 31. Italy Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Revenue, (US$, Mn), 2018-2029
Figure 32. Russia Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Revenue, (US$, Mn), 2018-2029
Figure 33. Nordic Countries Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Revenue, (US$, Mn), 2018-2029
Figure 34. Benelux Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Revenue, (US$, Mn), 2018-2029
Figure 35. By Region - Asia Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Revenue Market Share, 2018-2029
Figure 36. By Region - Asia Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Sales Market Share, 2018-2029
Figure 37. China Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Revenue, (US$, Mn), 2018-2029
Figure 38. Japan Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Revenue, (US$, Mn), 2018-2029
Figure 39. South Korea Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Revenue, (US$, Mn), 2018-2029
Figure 40. Southeast Asia Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Revenue, (US$, Mn), 2018-2029
Figure 41. India Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Revenue, (US$, Mn), 2018-2029
Figure 42. By Country - South America Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Revenue Market Share, 2018-2029
Figure 43. By Country - South America Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Sales Market Share, 2018-2029
Figure 44. Brazil Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Revenue, (US$, Mn), 2018-2029
Figure 45. Argentina Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Revenue, (US$, Mn), 2018-2029
Figure 46. By Country - Middle East & Africa Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East & Africa Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Sales Market Share, 2018-2029
Figure 48. Turkey Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Revenue, (US$, Mn), 2018-2029
Figure 49. Israel Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Revenue, (US$, Mn), 2018-2029
Figure 50. Saudi Arabia Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Revenue, (US$, Mn), 2018-2029
Figure 51. UAE Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Revenue, (US$, Mn), 2018-2029
Figure 52. Global Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Production Capacity (K Units), 2018-2029
Figure 53. The Percentage of Production Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine by Region, 2022 VS 2029
Figure 54. Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Industry Value Chain
Figure 55. Marketing Channels


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • ジフテリア/破傷風/百日咳（DPT）ワクチンのグローバル市場展望 2023年-2029年：DTwP型、DTaP型
  • 世界のジフテリア破傷風百日せきワクチン市場2022年：市場規模予測（～2028年）
  • 破傷風ワクチンのグローバル市場展望 2023年-2029年：ジフテリア・破傷風（DT）ワクチン、ジフテリア・破傷風・百日咳（百日咳）（DTaP）ワクチン、破傷風・ジフテリア（Td）ワクチン、破傷風・ジフテリア・百日咳（Tdap）ワクチン
  • 百日咳菌検査キットのグローバル市場展望 2023年-2029年：診断用百日咳菌検査キット、研究用百日咳菌検査キット
  • ノロウイルス用ワクチンのグローバル市場展望 2023年-2029年：二価、四価、六価
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(MMG23DC14208 )"無細胞ジフテリア百日咳菌インフルエンザ菌B型混合ワクチンのグローバル市場展望 2023年-2029年：0.5mL用量、1.5mL用量" (英文：Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Market, Global Outlook and Forecast 2023-2029)はMarket Monitor Global社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。